Temporal Trends in COVID-19 associated AKI from March to December 2020 in New York City

Author:

Dellepiane SergioORCID,Vaid AkhilORCID,Jaladanki Suraj KORCID,Paranjpe Ishan,Coca Steven,Fayad Zahi AORCID,Charney Alexander WORCID,Bottinger Erwin P,He John Cijiang,Glicksberg Benjamin SORCID,Chan LiliORCID,Nadkarni GirishORCID

Abstract

AbstractAcute Kidney Injury (AKI) is among the most common complications of Coronavirus Disease 2019 (COVID-19). Throughout 2020 pandemic, the clinical approach to COVID-19 has progressively improved, but it is unknown how these changes have affected AKI incidence and severity. In this retrospective analysis, we report the trend over time of COVID-19 associated AKI and need of renal replacement therapy in a large health system in New York City, the first COVID-19 epicenter in United States.

Publisher

Cold Spring Harbor Laboratory

Reference6 articles.

1. Chan L , Chaudhary K , Saha A , Chauhan K , Vaid A , Zhao S , Paranjpe I , Somani S , Richter F , Miotto R , Lala A , Kia A , Timsina P , Li L , Freeman R , Chen R , Narula J , Just AC , Horowitz C , Fayad Z , Cordon-Cardo C , Schadt E , Levin MA , Reich DL , Fuster V , Murphy B , He JC , Charney AW , Böttinger EP , Glicksberg BS , Coca SG , Nadkarni GN , Center (MSCIC) on behalf of the MSCI: AKI in Hospitalized Patients with COVID-19. J Am Soc Nephrol [Internet] 2020 Available from: https://jasn.asnjournals.org/content/early/2020/09/02/ASN.2020050615 [cited 2020 Nov 30]

2. Acute Kidney Injury in COVID-19 Patients: An Inner City Hospital Experience and Policy Implications;Am J Nephrol,2020

3. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report. N Engl J Med 0: ull, 2020

4. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

5. Excess Deaths Associated with COVID-19 [Internet]. 2020 Available from: https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm [cited 2021 Jan 5]

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3